| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/19/2001 | CA2388962A1 A molecular framework for amino acids or heterologous amino acid sequences |
| 04/19/2001 | CA2388681A1 Methods for treating pain |
| 04/19/2001 | CA2388253A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | CA2388224A1 Novel c-type lectin and gene thereof |
| 04/19/2001 | CA2388053A1 Cationic dosper virosomes |
| 04/19/2001 | CA2387629A1 Modified plant viruses and methods of use thereof |
| 04/19/2001 | CA2387604A1 Peptides which stimulate the immune response and tissue regeneration |
| 04/19/2001 | CA2387545A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | CA2387541A1 Short segments of dap-kinase |
| 04/19/2001 | CA2387355A1 Methods and compositions for correlating ccr5 expression with essential hypertension |
| 04/19/2001 | CA2387314A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | CA2387231A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387205A1 Interferon complex and pharmaceutical use thereof |
| 04/19/2001 | CA2387188A1 Vip54 protein and related materials |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2387145A1 Liposome encapsulated silver salt compositions |
| 04/19/2001 | CA2386848A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | CA2386177A1 Oculomedin and glaucoma |
| 04/19/2001 | CA2385784A1 Antimicrobial compositions comprising multidrug efflux pumps |
| 04/19/2001 | CA2385196A1 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | CA2385186A1 Induction of a strong immune response to a self-tumor associated antigen |
| 04/19/2001 | CA2385123A1 Method of altering polypeptide aggregation |
| 04/19/2001 | CA2385096A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | CA2382727A1 Methods of enhancing chemotherapy with the use of an imidazole |
| 04/19/2001 | CA2289365A1 Methods and compositions for predicting, diagnosing and treating lipodystrophy |
| 04/18/2001 | EP1092777A1 Self-cleaving RNA sequences and their use for the control of protein synthesis. |
| 04/18/2001 | EP1092773A2 Polypeptide and uses thereof |
| 04/18/2001 | EP1092772A1 Antibody against lar phosphatase subunit |
| 04/18/2001 | EP1092770A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/18/2001 | EP1092727A2 G-protein receptor |
| 04/18/2001 | EP1092726A2 Radioactively-labeled somatostatin derived peptides for imaging and therapeutics uses |
| 04/18/2001 | EP1092724A2 Angiotensin converting enzyme inhibitor |
| 04/18/2001 | EP1092438A1 Pharmaceutical compositions containing growth-hormone inhibitors or their biologically active fragments for the treatment of uterine myomas |
| 04/18/2001 | EP1092437A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 04/18/2001 | EP1092429A1 Pharmaceutical preparations for drugs of low solubility |
| 04/18/2001 | EP1092427A1 Use of a peptide avoiding skin intolerance reactions, especially in cosmetic compositions |
| 04/18/2001 | EP1092038A1 OCT1p, A PROTEIN HAVING HOMOLOGY TO THE ORGANIC AND SUGAR TRANSPORTER FAMILY OF PROTEINS, AND USES THEREOF |
| 04/18/2001 | EP1092032A2 Human oxidoreductase proteins |
| 04/18/2001 | EP1092031A2 Marburg virus vaccines |
| 04/18/2001 | EP1092030A2 Flt3-l mutants and methods of use |
| 04/18/2001 | EP1092029A1 A novel human thrombopoietin mutein |
| 04/18/2001 | EP1092027A1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same |
| 04/18/2001 | EP1092026A2 Neurotransmission associated proteins |
| 04/18/2001 | EP1092025A1 Human emr1-like g protein coupled receptor |
| 04/18/2001 | EP1092023A2 Molecules associated with apoptosis |
| 04/18/2001 | EP1092022A2 Immune system molecules |
| 04/18/2001 | EP1092020A1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid |
| 04/18/2001 | EP1092019A1 Human homologue of unc-53 protein of c. elegans |
| 04/18/2001 | EP1092018A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 04/18/2001 | EP1092013A1 3'-exonuclease, production and use thereof |
| 04/18/2001 | EP1092010A2 Porcine spinal cord cells and their use in spinal cord repair |
| 04/18/2001 | EP1091975A1 Novel cyclosporin with improved activity profile |
| 04/18/2001 | EP1091966A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 04/18/2001 | EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/18/2001 | EP1091774A1 Bone cement with antimicrobial peptides |
| 04/18/2001 | EP1091759A2 Composition for the induction of apoptosis in target cells |
| 04/18/2001 | EP1091755A1 Particulate delivery systems and methods of use |
| 04/18/2001 | EP1091754A1 Crosslink-stabilized indolicidin analogs |
| 04/18/2001 | EP1091753A1 Antiproliferative and antiviral proteins and peptides |
| 04/18/2001 | EP1091752A1 Compositions comprising endotoxin neutralizing protein and derivatives and uses thereof |
| 04/18/2001 | EP1091751A1 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof |
| 04/18/2001 | EP1091750A1 Cerebrospinal and vascular pharmaceutical composition and process for preparing the same |
| 04/18/2001 | EP1091739A1 Method for inhibiting c-jun expression using jak-3 inhibitors |
| 04/18/2001 | EP1091735A1 Application for utility patent for improved enriched platelet wound healant |
| 04/18/2001 | EP1091730A1 Utilization of growth factors for the production of medicaments |
| 04/18/2001 | EP1091729A1 Microparticle formulation for inhalation |
| 04/18/2001 | EP0970126B1 Novel method for the production of antihuman antigen receptors and uses thereof |
| 04/18/2001 | EP0851872B1 Urogenital carcinoma tlp complex peptides and antibodies thereof |
| 04/18/2001 | EP0802795A4 Neurological drug screens |
| 04/18/2001 | EP0766566B1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 04/18/2001 | EP0725790B1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
| 04/18/2001 | CN1292032A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/18/2001 | CN1292029A Compounds for therapy and diagnosis for lung cancer and method for their use |
| 04/18/2001 | CN1291994A New salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-2-(methylcarbamoyl)-2-phenylethyl) carbamoyl)-2-(2-naphtyl) ethyl) amide |
| 04/18/2001 | CN1291993A Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 04/18/2001 | CN1291992A Isolated, polypeptides which bind to HLA-A29 molecules, nucleic acid, molecules encoding there, and uses thereof |
| 04/18/2001 | CN1291991A Novel peptide having biological activity |
| 04/18/2001 | CN1291898A Remedies for corneal epithelium disturbance |
| 04/18/2001 | CN1064710C Therapeutic uses of keratinocyte growth factor |
| 04/18/2001 | CA2321437A1 Dna encoding structural protein-1 of infectious salmon anaemia virus and uses thereof |
| 04/17/2001 | US6218596 Enhancement of musculature in non-human mammals expressing c-ski |
| 04/17/2001 | US6218528 MurB |
| 04/17/2001 | US6218526 Polynucleotide encoding human netrin-1 |
| 04/17/2001 | US6218525 Nucleic acid encoding CD28 |
| 04/17/2001 | US6218522 Nucleotide sequences associated with the inhibition of gene expression; for detecting cancer; viricides |
| 04/17/2001 | US6218521 Isolated nucleic acid molecules associated with gastric cancer and methods for diagnosing and treating gastric cancer |
| 04/17/2001 | US6218520 Nucleotide probe for the detection of preferential proteins; for treatment of reproductive defcets, inflammatory and autoimmune diseases |
| 04/17/2001 | US6218517 Protein having a vascularization inhibitory effect and a method for production thereof and a method for producing angiostatin |
| 04/17/2001 | US6218513 Genetically engineered hemoglobins; for used to treat anemia and hemorrhages; for amplification of cells oxygen carrying capabilities |
| 04/17/2001 | US6218511 Anti-apoptotic genes of human cytomegalovirus (HCMV) and their use |
| 04/17/2001 | US6218509 LH/CG receptor, DNA and use thereof |
| 04/17/2001 | US6218506 Soluble brain protein for the detection, prevention and treatment of alzhiemer's disease |
| 04/17/2001 | US6218423 Administering pyrrolidine derivative for therapy of nerve-related vision disorder, improving vision, treating memory impairment, or enhancing memory performance in animal |
| 04/17/2001 | US6218417 Ace-inhibitor nitric salts |
| 04/17/2001 | US6218398 Nocathiacin antibiotics |
| 04/17/2001 | US6218382 For prophylaxis or therapy of thrombosis |
| 04/17/2001 | US6218372 Methods for treating restenosis with p21 |
| 04/17/2001 | US6218371 Administering immunopotentiating cytokine selected from group consisting of gm-csf, il-2, il-4 and ifn-.gamma., and immunostimulatory cpg oligonucleotide for inducing synergistic antigen specific immune response |
| 04/17/2001 | US6218370 Useful for cell transfection |
| 04/17/2001 | US6218365 Serine protease inhibitors |